rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mark W. Kroll

Director

Company insider

Files Form 4 as: Director, Haemonetics; Director, Axon Enterprise; Director, NewCardio.

In numbers

Trades disclosed
154
Buys
1
Sells
17
Bought
$99K
Sold
$9.9M
Companies
3
Companies where not an officer
3
First trade
7 Jan 2004
Last trade
24 Jul 2026
Last filed
28 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
HAE HaemoneticsDirector · Medical Devices · last 24 Jul 20261 buy · 10 sells
AXON Axon EnterpriseDirector · Aerospace & Defense · last 12 May 20230 buys · 7 sells
NewCardioDirector · last 18 Mar 20080 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
24 Jul 2026filed 28 Jul 2026HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,538filing
24 Jul 2026filed 28 Jul 2026HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,538filing
10 Nov 2025filed 12 Nov 2025HAE HaemoneticsMedical DevicesSEC FORM 4 Bought$99K1,400 at $70.56filing
24 Jul 2025filed 25 Jul 2025HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,693filing
25 Jul 2024filed 26 Jul 2024HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,207filing
4 Aug 2023filed 8 Aug 2023HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,226filing
12 May 2023filed 15 May 2023AXON Axon EnterpriseAerospace & DefenseSEC FORM 4 Code A—993 at $0.00filing
7 Mar 2023filed 8 Mar 2023AXON Axon EnterpriseAerospace & DefenseSEC FORM 4 Sold$20K92 at $220.85filing
7 Mar 2023filed 8 Mar 2023AXON Axon EnterpriseAerospace & DefenseSEC FORM 4 Sold$763K3,457 at $220.72filing
15 Aug 2022filed 16 Aug 2022HAE HaemoneticsMedical DevicesSEC FORM 4 Sold$591K8,016 at $73.71filing
5 Aug 2022filed 8 Aug 2022HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—2,730filing
8 Jun 2022filed 9 Jun 2022AXON Axon EnterpriseAerospace & DefenseSEC FORM 4 Sold$325K3,159 at $102.82filing
20 May 2022filed 23 May 2022AXON Axon EnterpriseAerospace & DefenseSEC FORM 4 Code A$200K2,013 at $99.40filing
6 Aug 2021filed 9 Aug 2021HAE HaemoneticsMedical DevicesSEC FORM 4 Code A—3,077filing
27 May 2021filed 1 Jun 2021AXON Axon EnterpriseAerospace & DefenseSEC FORM 4 Code A$200K1,434 at $139.48filing
26 May 2021filed 28 May 2021HAE HaemoneticsMedical DevicesSEC FORM 4 Code M$368K10,353 at $35.50filing
26 May 2021filed 28 May 2021HAE HaemoneticsMedical DevicesSEC FORM 4 Sold$651K11,813 at $55.10filing
26 May 2021filed 28 May 2021HAE Haemoneticsoption or derivative · Medical DevicesSEC FORM 4 Code M—10,353 at $0.00filing
12 May 2021filed 14 May 2021AXON Axon EnterpriseAerospace & DefenseSEC FORM 4 Sold$525K4,204 at $124.94filing
19 Jan 2021filed 21 Jan 2021AXON Axon EnterpriseAerospace & DefenseSEC FORM 4 Code G—1,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care11
Industrials7

Buys in green, sells in red, by the company’s sector.

Related people

Robert E. AbernathyDirector · Director at Haemonetics, filing Form 4 there in the last year
Michael J. CoyleDirector · Director at Haemonetics, filing Form 4 there in the last year
Martin D. MadausInterim CEO · Director at Haemonetics, filing Form 4 there in the last year
Ellen M. ZaneDirector · Director at Haemonetics, filing Form 4 there in the last year
Claire PomeroyDirector · Director at Haemonetics, filing Form 4 there in the last year
Isaiah FieldsChief Legal Officer · Also traded AXON in the last 90 days
Patrick W. SmithChief Executive Officer · Also traded AXON in the last 90 days
Joshua IsnerPresident · Also traded AXON in the last 90 days